Get started
Award

CL-2018-11-002

Funded outputs count: 23
Funder award ID: CL-2018-11-002
OpenAlex ID: G5579656647
Individual participant data from digital sources informed and improved precision in the evaluation of predictive biomarkers in Bayesian network meta-analysis
2023 · Chinyereugo M. Umemneku-Chikere, Lorna Wheaton, et al. · Journal of Clinical Epidemiology · 2
PDF
Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review
2023 · Emma L. O’Dowd, Samuel W. D. Merriel, et al. · BMC Cancer · 14
PDF
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
2023 · Thomas Starkey, Maria C. Ionescu, et al. · Scientific Reports · 20
PDF
Lung cancer in never smokers (LCINS): development of a UK national research strategy
2023 · Sam Khan, Nathaniel Hatton, et al. · BJC Reports · 21
PDF
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research
2023 · Matthew Fittall, Justin Liu, et al. · British Journal of Cancer · 3
PDF
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer
2022 · Lennard Y. W. Lee, Michael Tilby, et al. · JAMA Oncology · 32
PDF
Safe prescribing in cancer patients during the COVID ‐19 pandemic: A new initiative from the UK Cancer Coronavirus Project ( UKCCP ) team
2022 · Nathan Appanna, Grisma Patel, et al. · International Journal of Cancer · 1
The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status
2022 · Heather Poad, Sam Khan, et al. · Cancers · 7
PDF
Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapies
2022 · Sam Khan, Gareth J Miles, et al. · Mutagenesis · 9
Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups
2022 · Chinyereugo M. Umemneku-Chikere, Olubukola Ayodele, et al. · Frontiers in Oncology · 3
PDF
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
2022 · Oskar Wysocki, Cong Zhou, et al. · Cancers · 2
PDF
Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer
2022 · Savvas Papageorgiou, Sarah L. Pashley, et al. · Cancers · 17
PDF
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study
2022 · Lennard Y.W. Lee, Maria C. Ionescu, et al. · European Journal of Cancer · 57
PDF
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study
2022 · Lennard Y W Lee, Thomas Starkey, et al. · The Lancet Oncology · 94
PDF
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
2022 · Rebecca J. Lee, Oskar Wysocki, et al. · JCO Clinical Cancer Informatics · 14
PDF
EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity
2022 · Kellie Lucken, Laura O'Regan, et al. · Molecular Cancer Research · 15
PDF
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
2021 · Chara Stavraka, Athanasios Pouptsis, et al. · Clinical Colorectal Cancer · 16
PDF
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit
2021 · Alexa Childs, Nekisa Zakeri, et al. · British Journal of Cancer · 42
PDF
A Systematic Review Assessing Clinical Utility of Curcumin with a Focus on Cancer Prevention
2021 · Lynne Howells, Rushad Malhotra Mukhtyar, et al. · Molecular Nutrition & Food Research · 25
PDF
Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’
2021 · R.J. Lee, O. Wysocki, et al. · ESMO Open
PDF
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
2021 · R.J. Lee, O. Wysocki, et al. · ESMO Open · 18
PDF
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
2020 · Lennard Y W Lee, Jean-Baptiste Cazier, et al. · The Lancet Oncology · 574
PDF
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
2020 · Lennard YW Lee, Jean-Baptiste Cazier, et al. · The Lancet · 1,102
PDF
Year
Topic